Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Revenue

    Back to Income Statement
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹11,813 Cr₹11,583 Cr₹12,305 Cr₹10,944 Cr₹10,641 Cr

What is the latest Revenue of GLENMARK PHARMACEUTICALS ?

The latest Revenue ratio of GLENMARK PHARMACEUTICALS is ₹11,813 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹11,813 Cr
Mar2024₹11,583 Cr
Mar2023₹12,305 Cr
Mar2022₹10,944 Cr
Mar2021₹10,641 Cr

How is Revenue of GLENMARK PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹11,813 Cr
1.98
Mar2024 ₹11,583 Cr
-5.86
Mar2023 ₹12,305 Cr
12.44
Mar2022 ₹10,944 Cr
2.85
Mar2021 ₹10,641 Cr -

Compare Revenue of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹62,240.6 Cr -3.9% 0.4% 0.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,842.0 Cr -0.4% 4.3% 13.6% Stock Analytics
DIVIS LABORATORIES ₹193,860.0 Cr 0.9% 8.9% 8% Stock Analytics
TORRENT PHARMACEUTICALS ₹192,687.0 Cr 0.7% 13% 46.5% Stock Analytics
CIPLA ₹112,593.0 Cr -1% -0% -3.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,364.9 Cr -3.3% -8.4% -4.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.9%

0.4%

0.7%

SENSEX

-1%

-0.9%

-7.5%


You may also like the below Video Courses